Searchable abstracts of presentations at key conferences in endocrinology

ea0081p569 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metabolic dysfunction–associated fatty liver disease and cardiovascular risk characterization

Perdomo Carolina M. , Nunez Jorge , Casajus Ana Ezponda , Mendoza Francisco J. , Aleman Gorka Bastarrika , Fruhbeck Gema , Escalada Javier

Objectives: Metabolic dysfunction–associated fatty liver disease (MAFLD) is a new nomenclature for fatty liver disease (FLD). The clinical impact of the change in nomenclature on the ability to identify individuals at risk for cardiovascular disease (CVD) has not yet been elucidated. The aim of this study is to describe the cardiovascular risk and subclinical CVD of the different MAFLD subtypes.Methods: Retrospective analysis of patients who attende...

ea0090p78 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Epicardial Fat, a cardiovascular risk factor with implications in kidney function

Perdomo Carolina M. , Martin-Calvo Nerea , Ezponda Casajus Ana , Mendoza Francisco J. , Bastarrika Aleman Gorka , de Assuncao Guilherme V. , Garcia-Fernandez Nuria , Fruhbeck Gema , Escalada Javier

Aim: Epicardial adipose tissue (EAT) has important physiologic functions, nonetheless, excessive EAT leads to a proinflammatory state with adverse effects on the myocardium. EAT has also been associated with adverse outcomes in chronic kidney disease (CKD) patients. We think that visceral adipose tissue (VAT) and organ-specific ectopic fat plays an important role in cardiorenal dysfunction. The aim of our study is to analyse the relationship between EAT and the risk of develop...